Skip to main content
AkademIndex

Products

For developers

AkademBaseOpen API for the ecosystem
← Back to work

Works cited by this work

264 works

Work: The emerging microbiome‐based approaches to <scp>IBD</scp> therapy: From <scp>SCFAs</scp> to urolithin A

  1. TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading

    Thijs W.H. Pols, Mitsunori Nomura, Taoufiq Harach +9

    Article20112 citations
    ABI

  2. Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

    Noortje Rossen, Susana Fuentes, Mirjam J. van der Spek +10

    Article20152 citations
    ABI

  3. The gut microbiota, bacterial metabolites and colorectal cancer

    Petra Louis, Georgina L. Hold, Harry J. Flint

    Review article20142 citations
    ABI

  4. Biological Significance of Urolithins, the Gut Microbial Ellagic Acid-Derived Metabolites: The Evidence So Far

    Juan Carlos Espı́n, Mar Larrosa, María‐Teresa García‐Conesa +1

    Article20132 citations
    ABI

  5. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

    Daniel N. Frank, Allison L. St. Amand, Robert A. Feldman +3

    Article20072 citations
    ABI

  6. Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells

    Koji Atarashi, Takeshi Tanoue, Minoru Ando +28

    Article20152 citations
    ABI

  7. The Impact of the Level of the Intestinal Short Chain Fatty Acids in Inflammatory Bowel Disease Patients Versus Healthy Subjects

    Nur Huda Faujan, A.S. Abdulamir, A. B. Fatimah +4

    Article20102 citations
    ABI

  8. A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis

    Kathleen Machiels, Marie Joossens, João Sabino +11

    Article20132 citations
    ABI

  9. From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites

    Ara Koh, Filipe De Vadder, Petia Kovatcheva‐Datchary +1

    Review article20162 citations
    ABI

  10. U.S. Regulatory Considerations for Development of Live Biotherapeutic Products as Drugs

    Sheila M. Dreher‐Lesnick, Scott Stibitz, Paul E. Carlson

    Article20172 citations
    ABI

  11. Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway

    Rajbir Singh, Sandeep Chandrashekharappa, Sobha R. Bodduluri +18

    Article20192 citations
    ABI

  12. The Effect of Probiotics on the Production of Short-Chain Fatty Acids by Human Intestinal Microbiome

    Paulina Markowiak‐Kopeć, Katarzyna Śliżewska

    Review article20202 citations
    ABI

  13. Host–microbiota interactions in immune-mediated diseases

    William Ruff, Teri M. Greiling, Martin Kriegel

    Review article20202 citations
    ABI

  14. Untitled

    Other1 citations
    ABI

  15. Untitled

    Other1 citations
    ABI

  16. Untitled

    Other1 citations
    ABI

  17. Untitled

    Other1 citations
    ABI

  18. Untitled

    Other1 citations
    ABI

  19. Untitled

    Other1 citations
    ABI

  20. Untitled

    Other1 citations
    ABI

  21. Untitled

    Other1 citations
    ABI

  22. Untitled

    Other1 citations
    ABI

  23. Untitled

    Other1 citations
    ABI

  24. Untitled

    Other1 citations
    ABI

  25. Untitled

    Other1 citations
    ABI